Eagle Pharmaceuticals
EGRX
#8886
Rank
ยฃ42.16 M
Marketcap
ยฃ3.25
Share price
-0.23%
Change (1 day)
-73.70%
Change (1 year)

Revenue for Eagle Pharmaceuticals (EGRX)

Revenue in 2023 (TTM): ยฃ0.21 B

According to Eagle Pharmaceuticals 's latest financial reports the company's current revenue (TTM) is ยฃ0.19 B. In 2022 the company made a revenue of ยฃ0.26 B an increase over the revenue in the year 2021 that were of ยฃ0.12 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Eagle Pharmaceuticals from 2013 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) ยฃ0.21 B-18.25%
2022 ยฃ0.26 B106.47%
2021 ยฃ0.12 B-7.86%
2020 ยฃ0.13 B-6.81%
2019 ยฃ0.14 B-11.7%
2018 ยฃ0.16 B-4.55%
2017 ยฃ0.17 B14.05%
2016 ยฃ0.15 B243.97%
2015 ยฃ44.64 M261.83%
2014 ยฃ12.33 M15.2%
2013 ยฃ10.71 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ65.96 B 33,515.09%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ30.07 B 15,223.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ37.22 B 18,871.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ12.41 B 6,224.96%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
ยฃ23.57 B 11,910.83%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ29.65 B 15,012.66%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ35.43 B 17,958.17%๐Ÿ‡บ๐Ÿ‡ธ USA